公司概覽
業務類別 Medical Instruments & Supplies
業務概覽 Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%,and 19% of revenue, respectively.
公司地址 41 Seyon Street, Building 1, Suite 100, Waltham, MA, USA, 02453
電話號碼 +1 781 250-0111
傳真號碼 +1 781 250-0115
公司網頁 https://www.repligen.com
員工數量 2000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Ralf Kuriyel, PhD Senior Vice President, Research and Development 美元 420.55K 02/04/2026
Mr. Jason K. Garland Chief Financial Officer 美元 566.50K 02/04/2026
Mr. James R. Bylund Chief Operating Officer 美元 481.20K 02/04/2026
Ms. Violetta A. Hughes Chief Accounting Officer -- 26/02/2026
Mr. Olivier Loeillot Director, President and Chief Executive Officer 美元 860.00K 02/04/2026
Mr. Brian Robb Douglass Senior Vice President and Chief Product Officer 美元 417.15K 02/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. Glenn P. Muir Independent Director 02/04/2026
Mr. Nicolas M. Barthelemy Independent Director 02/04/2026
Dr. Martin D. Madaus,PhD Chairman of the Board 06/01/2026
Ms. Carrie Eglinton Manner Independent Director 02/04/2026
Dr. Rohin Mhatre, PhD Independent Director 02/04/2026
Dr. Konstantin Konstantinov, PhD Independent Director 02/04/2026
Mr. Olivier Loeillot Director, President and Chief Executive Officer 02/04/2026
Ms. Margaret A. Pax Independent Director 02/04/2026
 
所屬ETF (更新日期: 14/11/2026 04:11)
代號 名稱 佔比% ▼ 持有日期
XJRiShares ESG Select Scrn S&P Small-CapETF0.00002%30/10/2026
AVUCAvantis U.S. Core Equity ET0.000003%30/10/2026
ACSGAmerican Century Small Cp Gr Insgts ETF<0.000001%01/10/2026
ACSVAmerican Century Small Cp Val Insgts ETF<0.000001%01/10/2026
CPZCalamos L/S Equity & Dynamic Inc Trust<0.000001%31/08/2026
CTAGCalamos Timpani Active SMID Growth ETF<0.000001%28/02/2026
CVSECalvert US Select Equity ETF<0.000001%20/08/2025
HDGProShares Hedge Replication<0.000001%08/10/2026
IJRiShares Core S&P Small-Cap ETF<0.000001%08/10/2026
IJSiShares S&P Small-Cap 600 Value ETF<0.000001%08/10/2026
IJTiShares S&P Small-Cap 600 Growth ETF<0.000001%08/10/2026
ITWOProShares Russell 2000 High Income ETF<0.000001%08/10/2026
IWCiShares Micro-Cap ETF<0.000001%08/10/2026
IWMiShares Russell 2000 ETF<0.000001%08/10/2026
IWNiShares Russell 2000 Value ETF<0.000001%08/10/2026
IWOiShares Russell 2000 Growth ETF<0.000001%08/10/2026
JHSCJHancock Multifactor Small Cap ETF<0.000001%17/09/2026
KATScharf ETF<0.000001%29/08/2025
KBFRInnovator U.S. Small Cap Mgd 10 Bfr ETF<0.000001%28/10/2026
LITLSimplify Piper Sandler USSm-CpPLUSIncETF<0.000001%08/10/2026
  1    2    3    4    5    6    7   8    9    10  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.